AIM
IART icon

Access Investment Management’s Integra LifeSciences IART Stock Holding History

Access Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.27M Sell
405,002
-235,533
-37% -$3.29M 1.86% 20
2026
Q1 		$6.03M Buy
640,535
+268,085
+72% +$2.94M 1.61% 25
2025
Q4 		$5.34M Hold
372,450
– – 1.43% 27
2025
Q3 		$5.34M Sell
372,450
-63,420
-15% -$869K 1.43% 27
2025
Q2 		$5.35M Buy
+435,870
New +$6.33M 1.52% 24
2024
Q4 		$4.42M Buy
+194,715
New +$4.25M 1.28% 28

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Access Investment Management's IART Position: Q2 2026 in Review

Access Investment Management reduced its Integra LifeSciences (IART) stake by 37% in Q2 2026, selling an estimated $3.29M and leaving 405,002 shares worth $7.27M. The position accounts for 1.86% of the portfolio, ranked #20.

Access Investment Management first reported a position in IART in Q4 2024 and has held it in 6 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Access Investment Management held 405,002 shares of Integra LifeSciences worth $7.27M as of Q2 2026.
  • Access Investment Management sold 235,533 Integra LifeSciences shares in Q2 2026, an estimated $3.29M.
  • Integra LifeSciences made up 1.86% of Access Investment Management's portfolio in Q2 2026, its #20 holding.
  • Access Investment Management first reported a position in Integra LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Access Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.